Table 1 Association between LLGL2 and SLC7A5 mRNA expression and clinicopathological characteristics in ERĪ±-positive patients.
From: Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERĪ±-positive breast cancer
| Ā | LLGL2/SLC7A5 | P value | |||
|---|---|---|---|---|---|
Low/low | High/low | Low/high | High/high | ||
n (%) | n (%) | n (%) | n (%) | ||
Patients | 84 | 91 | 175 | 141 | Ā |
Menopausal status | |||||
Pre | 44 (52) | 43 (47) | 75 (43) | 54 (38) | 0.19 |
Post | 40 (48) | 48 (53) | 100 (57) | 87 (62) | Ā |
Tumor size | |||||
āā¤ā2Ā cm | 29 (35) | 45 (50) | 71 (40) | 62 (44) | 0.22 |
ā>ā2Ā cm | 55 (65) | 46 (50) | 104 (60) | 79 (56) | Ā |
Unknown | 0 | 0 | 0 | 0 | Ā |
Nodal status | |||||
Negative | 56 (66) | 50 (55) | 95 (54) | 57 (40) | 0.001 |
Positive | 24 (29) | 37 (41) | 72 (41) | 76 (54) | Ā |
Unknown | 4 (5) | 4 (4) | 8 (5) | 8 (6) | Ā |
Grade | |||||
1ā+ā2 | 64 (76) | 64 (70) | 101 (58) | 86 (61) | 0.011 |
3 | 18 (22) | 25 (28) | 71 (40) | 50 (35) | Ā |
Unknown | 2 (2) | 2 (2) | 3 (2) | 5 (4) | Ā |
pStage TNM* | |||||
I | 27 (32) | 30 (33) | 51 (29) | 36 (26) | 0.80 |
II | 44 (52) | 43 (47) | 83 (47) | 71 (50) | Ā |
III | 9 (11) | 13 (14) | 33 (19) | 24 (17) | Ā |
Unknown | 4 (5) | 5 (5) | 8 (5) | 10 (7) | Ā |
Histology | |||||
IDC | 73 (88) | 79 (85) | 160 (91) | 126 (89) | 0.35 |
ILC | 4 (4) | 6 (7) | 5 (3) | 11 (8) | Ā |
Others | 6 (7) | 6 (7) | 10 (6) | 4 (3) | Ā |
Unknown | 1 (1) | 0 | 0 | 0 | Ā |
PgR status | |||||
Positive | 76 (85) | 76 (90) | 155 (89) | 119 (84) | 0.39 |
Negative | 8 (15) | 15 (10) | 20 (11) | 22 (16) | Ā |
Unknown | 0 | 0 | 0 | 0 | Ā |
HER2 status | |||||
Positive | 6 (7) | 11 (12) | 15 (9) | 13 (9) | 0.73 |
Negative | 75 (89) | 78 (86) | 152 (87) | 124 (88) | Ā |
Unknown | 3 (4) | 2 (2) | 8 (4) | 4 (3) | Ā |
Adjuvant therapy | |||||
ET alone | 56 (67) | 47 (52) | 85 (49) | 63 (45) | Ā |
CT alone | 3 (4) | 1 (1) | 19 (10) | 6 (4) | Ā |
ETā+āCT | 23 (27) | 34 (37) | 54 (31) | 62 (44) | Ā |
None | 2 (2) | 8 (9) | 12 (7) | 9 (6) | Ā |
Unknown | 0 | 1 (1) | 5 (3) | 1 (1) | Ā |
